News: Biotechnology

View:
 

Found press releases

 

YEAR END REPORT JANUARY – DECEMBER 2011

2/9/2012 3:00 AM EST  -   Artimplant

· Net revenue amounted to SEK 18.3 million (18.5).*
· The net loss totaled SEK 17.9 million (22.4).  
· Earnings per stock unit amounted to SEK -0.15 (-0.32).
· Own sales as a proportion of total sales continued to increase and accounted for 75% (61) of product sales.
· The Company's cash flow objective is to achieve a positive cash flow before changes in working capital on a monthly basis during the fourth...

Badger Explorer ASA – 4Q 2011 Investor Presentations

2/8/2012 4:42 PM EST  -   Badger Explorer ASA
The Company's 4Q 2011 investor presentations will take place in Oslo on Wednesday, 15 February 2012 and in Stavanger on Thursday, 16 February 2012.
The investor presentation in Oslo will take place at Hotel Continental on Wednesday, 15 February 2012 at 11:00 - 12:30. Light lunch will be served. The investor presentation in Stavanger will take place at Badger Explorer ASA's premises at Forusskogen 1, 4033...

Date change for Annual General Meeting and reports

2/7/2012 5:11 AM EST  -   Genovis AB
The Board of Directors of Genovis AB (publ) has decided to hold the Annual General Meeting earlier on March 20, 2012. The notice convening the AGM will appear in Post och Inrikes Tidningar and an ad will be published in the newspaper Dagens Industri on February 21.

The Interim Report for January-March, which was to be announced on April 26, will be postponed. The new publication date for the report is May 22.

The...

Report on operations 2011

2/7/2012 2:30 AM EST  -   Vitrolife AB (publ)
A quarter of record sales and one-time expenses
Fourth quarter

· Sales increased by 19 percent in local currency. Sales were the highest ever for a single quarter and amounted to SEK 95 (81) million, corresponding to an increase of 18 percent in SEK.
· Operating income (EBIT) amounted to SEK 4 (9) million. The operating margin was 4 (11) percent. One-time expenses of SEK 7 million are included and consist of...

Precise Biometrics Launches Next Generation of Mobile Security - Year-end report...

2/3/2012 2:00 AM EST  -   Precise Biometrics
Precise Biometrics AB (publ), Corporate Identity No. 556545-6596
Year-end report for the period January – December 2011

· The group’s net sales for the financial year was SEK 21.6 million (44.9) and for the fourth quarter SEK 4.8 million (6.3).

· The group’s result for the year was SEK-33.2 million (-14.6) and for the fourth quarter SEK -9.2 million (-4.4)

· Earning per share for the year amounted to SEK...

Low-dose menaquinone-7 supplementation improved extra-hepatic vitamin K status, ...

2/2/2012 3:13 AM EST  -   NattoPharma ASA
Theuwissen E, Cranenburg EC, Knapen MH, Magdeleyns EJ, Teunissen KJ, Schurgers LJ, Smit E, Vermeer C.

Br J Nutr. 2012 Jan 31:1-6. [Epub ahead of print]

Web Link: http://www.ncbi.nlm.nih.gov/pubmed/22289649

Background
Recently a publication in the American Journal of Kidney Disease showed beneficial effects of natural vitamin K2 (MenaQ7®) supplementation in dialysis...

Conference call Year-end report 2011

1/31/2012 3:30 AM EST  -   Vitrolife AB (publ)
Invitation to attend Vitrolife’s conference call regarding presentation of the Year-end report for 2011. The presentation will be held in English.
Time: Tuesday, February 7, 2012 at 10.00 a.m. CET.
Registration can preferably be done in advance under the following link:
https://eventreg2.conferencing.com/webportal3/reg.html?Acc=526965&Conf=207356
or shortly before time of the conference starts on:
Sweden dial...

Next Generation of Mobile Security for Smart Devices: Smart Casings with Smart C...

1/25/2012 2:00 AM EST  -   Precise Biometrics
The smart casing is the first of its kind on the market. With a built-in smart card reader and fingerprint sensor, the product enables the highest level of security for network access, messaging, data protection and strong authentication to the most popular mobile platforms.
Precise Biometrics has developed a smart casing with a built-in smart card reader and fingerprint sensor. The product meets the increasing...

Artimplant takes over sales in the Nordic countries

1/19/2012 3:00 AM EST  -   Artimplant
Artimplant continues to strengthen its market position. Since the beginning of 2012, Artimplant has taken over the sales of their products on the Nordic market.
The former distributor, NMS, has filed for bankruptcy, enabling Artimplant to quickly take over the direct sales. This is a part of Artimplant's effort to increase its presence in markets where Artimplant's products are marketed and distributed.

Västra...

Positive results on “Clinical trial on beneficial effects of long term MenaQ7® (...

1/16/2012 1:45 AM EST  -   NattoPharma ASA
The data are presently evaluated but already it may be concluded that the results are positive and that the primary efficacy parameters are met.
In 2007 NattoPharma initiated a 3-year clinical intervention study on the effects of MenaQ7® on bone and cardiovascular health, respectively. Recruitment for the study started in early 2008 and the last measurements have been completed in the fall of 2011. The...